These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9989805)
1. IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180. Nie Z; Hashimoto T J Invest Dermatol; 1999 Feb; 112(2):254-5. PubMed ID: 9989805 [No Abstract] [Full Text] [Related]
2. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819 [TBL] [Abstract][Full Text] [Related]
3. Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180. Lee JB; Liu Y; Hashimoto T J Dermatol Sci; 2003 Jun; 32(1):59-64. PubMed ID: 12788530 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2. Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433 [No Abstract] [Full Text] [Related]
5. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132 [TBL] [Abstract][Full Text] [Related]
6. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. Balding SD; Prost C; Diaz LA; Bernard P; Bedane C; Aberdam D; Giudice GJ J Invest Dermatol; 1996 Jan; 106(1):141-6. PubMed ID: 8592065 [TBL] [Abstract][Full Text] [Related]
7. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. Smith EP; Taylor TB; Meyer LJ; Zone JJ J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534 [TBL] [Abstract][Full Text] [Related]
8. IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180. Nie Z; Nagata Y; Joubeh S; Hirako Y; Owaribe K; Kitajima Y; Hashimoto T J Invest Dermatol; 2000 Dec; 115(6):1164-6. PubMed ID: 11121162 [No Abstract] [Full Text] [Related]
9. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180. Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314 [TBL] [Abstract][Full Text] [Related]
10. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180. Shimanovich I; Skrobek C; Rose C; Nie Z; Hashimoto T; Bröcker EB; Zillikens D J Am Acad Dermatol; 2002 Nov; 47(5):780-4. PubMed ID: 12399776 [TBL] [Abstract][Full Text] [Related]
11. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787 [TBL] [Abstract][Full Text] [Related]
12. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen. Hashimoto T; Han-Yaku H; Higashiyama M; Hashimoto K; Iwatsuki K; Kaneko F; Murakami H; Nishikawa T Br J Dermatol; 1997 Aug; 137(2):305-6. PubMed ID: 9292089 [No Abstract] [Full Text] [Related]
13. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain. Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014 [No Abstract] [Full Text] [Related]
14. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions. Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276 [No Abstract] [Full Text] [Related]
15. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180. Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895 [No Abstract] [Full Text] [Related]
16. Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains. Uchiyama M; Mitsuhashi Y; Tsuboi R; Ishii N; Hayakawa T; Yasukochi A; Hashimoto T Indian J Dermatol Venereol Leprol; 2015; 81(6):637-9. PubMed ID: 26515855 [No Abstract] [Full Text] [Related]
17. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid. Li X; Qian H; Sogame R; Hirako Y; Tsuruta D; Ishii N; Koga H; Tsuchisaka A; Jin Z; Tsubota K; Fukumoto A; Sotozono C; Kinoshita S; Hashimoto T Eur J Dermatol; 2016 Jun; 26(3):247-53. PubMed ID: 27193492 [TBL] [Abstract][Full Text] [Related]
18. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472 [TBL] [Abstract][Full Text] [Related]
19. [Mucous membrane pemphigoid: IgG and IgA antibodies against the BP180 antigen]. España A; del Olmo J; Marquina M; Sitaru C Actas Dermosifiliogr; 2005; 96(6):365-70. PubMed ID: 16476255 [TBL] [Abstract][Full Text] [Related]
20. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. Bernard P; Prost C; Durepaire N; Basset-Seguin N; Didierjean L; Saurat JH J Invest Dermatol; 1992 Aug; 99(2):174-9. PubMed ID: 1629629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]